The associate professor at University College London also discussed unmet needs that remain in r/r B-ALL and another presentation of interest at ASCO’s 2023 conference.
Claire Roddie, MD, PhD, FRCPath, MBChB, MRCP
Advertisement
Articles by Claire Roddie, MD, PhD, FRCPath, MBChB, MRCP
The associate professor in haemato-oncology at University College London discussed Autolus Therapeutics’ CAR-T, which utilizes a novel fast off-rate CD19 binding domain.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – October 29, 2025
2
Quarter Century Update: Future Predictions for the Field
3
Naji Gehchan, MD, MBA, on Evaluating CAR-T KYV-101 for Generalized Myasthenia Gravis
4
Quarter Century Update: What Does the Field Need Most Right Now?
5
